DOUGLAS REED: Open Payments
NPI 1457641300 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 18 payments from 7 companies in 2025. Trend: 2023 $412 · 2024 $726 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $181 |
| Otsuka America Pharmaceutical, Inc. | 4 | $104 |
| Lundbeck LLC | 4 | $102 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| ABBVIE INC. | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, INGREZZA, REXULTI, VRAYLAR, UZEDY, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
